8 clinical trials found.
-
Prodromal and Early Parkinsonism Alpha-Synuclein Study
Single-center, cross-sectional biospecimen study of alpha-synuclein seed amplification assays in prodromal or early undifferentiated parkinsonism.Phase N/A
Accepts Healthy Volunteer
TRIAL ROLE: Principal Investigator
-
THE NEW YORK MOVEMENT DISORDER STUDY
Movement disorders represent a major public health crisis. Large longitudinal clinicopathological studies form the basis for studying the symptomatology, epidemiology, progression and pathogenesis of these ...Phase N/A Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
The Parkinson s Progression Markers Initiative (PPMI) 2.0 Clinical - Establishing a Deeply Phenotyped PD Cohort
The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital ...Phase N/A Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
EARLY DETECTION OF ALPHA-SYNUCLEIN DISEASE Single-center cross-sectional and longitudinal non-interventional observational study of biomarkers in prodromal synucleinopathy
Single-center, cross-sectional and longitudinal exploratory observational study of approximately 80 patients with diagnoses of pure autonomic failure (PAF), Parkinson´s Disease, Multiple System Atrophy, Lewy ...Phase N/A TRIAL ROLE: Sub Investigator
-
Movement Disorder Genomic Study
With the present study we aim to perform integrated genomic analysis and study on subject-specific cellular models in order to identify genetic causes of rare ...Phase N/A Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
Imaging the human eye using visible light Optical Coherence Tomography
We will perform non-invasive optical imaging of the retina in adult human subjects with a low power light beamPhase N/A Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
Young Onset Parkinson s disease Subtypes and Pathogenic Mechanisms
Young Onset Parkinson’s disease refers to a -group of patients in which the disease starts earlier in life (before the age of 50 years ...Phase N/A Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
An observational multi-center study to validate outcome measures for future clinical trials of Multiple System Atrophy (MSA)
The purpose of this research study is to develop and validate new methods to measure if a potential drug being tested in future clinical trials ...Phase N/A TRIAL ROLE: Sub Investigator
